Better Therapeutics, Inc. (BTTX) Social Stream
BETTER THERAPEUTICS INC (BTTX) Price Targets From Analysts
Use the tables below to see what analysts covering BETTER THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 13 months, BTTX's average price target has gone down $3.
Over the past 37 weeks, BTTX's average upside potential has been 541.88%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BTTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 153 days, BTTX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BETTER THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 962.25% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, BETTER THERAPEUTICS INC's variance in analysts' estimates is lower than 37.03% of them.
- In the context of Healthcare stocks, BETTER THERAPEUTICS INC's number of analysts covering the stock is higher than 100.27% of them.
- In terms of how BETTER THERAPEUTICS INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 272.08% of that group.
Make investment decisions regarding BTTX using the data that counts. Try POWR Ratings for free.